Standard BioTools Inc (LAB)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$1.42

Buy

$1.45

arrow-down$-0.03 (-2.03%)

Prices updated at 12 Dec 2025, 22:43 EST

Prices minimum 15 mins delay

Prices in USD

Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Thomas Carey

CEO

Dr. Michael Egholm, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

818

Head office

2 Tower Place

South San Francisco

United States

94080

+1 650 266-6000

agnes.lee@fluidigm.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Fenel M. Eloi Independent Director	0.07m
Ms. Kathy L. Hibbs, J.D. Director	0.06m
Dr. Michael Egholm, PhD President, Chief Executive Officer and Director	0.69m
Mr. Troy M. Cox, M.B.A. Director	0.07m
Mr. Eli D. Casdin, M.B.A. Independent Director	0.06m
Dr. Franklin R. Witney, PhD Independent Director	0.07m
Mr. Sean Mackay Chief Business Officer	0.29m
Mr. Hanjoon Alex Kim Chief Financial Officer and Principal Accounting Officer	0.49m
Mr. Thomas Carey Chairman of the Board	0.11m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Casdin Capital, LLC	77,558,856
Viking Global Investors LP	58,651,170
BlackRock Inc	24,920,918
Vanguard Group Inc. ( Junked)	17,292,092
Vanguard Group Inc	16,981,738

Director dealings

Date chevron-l-regular chevron-r-regular	Action
20 Nov 2024	-
20 Aug 2024	-
20 Aug 2024	-
15 Aug 2024	-
15 Aug 2024	-
15 Aug 2024	-
19 Jul 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
28 Jun 2024	-
20 May 2024	-
20 May 2024	-
20 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.